A citation-based method for searching scientific literature

Ruben P A van Eijk, Henk-Jan Westeneng, Stavros Nikolakopoulos, Iris E Verhagen, Michael A van Es, Marinus J C Eijkemans, Leonard H van den Berg. Neurology 2019
Times Cited: 36







List of co-cited articles
202 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
Henk-Jan Westeneng, Thomas P A Debray, Anne E Visser, Ruben P A van Eijk, James P K Rooney, Andrea Calvo, Sarah Martin, Christopher J McDermott, Alexander G Thompson, Susana Pinto,[...]. Lancet Neurol 2018
157
52


Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.
Leonard H van den Berg, Eric Sorenson, Gary Gronseth, Eric A Macklin, Jinsy Andrews, Robert H Baloh, Michael Benatar, James D Berry, Adriano Chio, Philippe Corcia,[...]. Neurology 2019
62
30

The PRO-ACT database: design, initial analyses, and predictive features.
Nazem Atassi, James Berry, Amy Shui, Neta Zach, Alexander Sherman, Ervin Sinani, Jason Walker, Igor Katsovskiy, David Schoenfeld, Merit Cudkowicz,[...]. Neurology 2014
134
27

ALS clinical trials: do enrolled patients accurately represent the ALS population?
A Chiò, A Canosa, S Gallo, S Cammarosano, C Moglia, G Fuda, A Calvo, G Mora. Neurology 2011
67
27

Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
Hiroshi Mitsumoto, Benjamin R Brooks, Vincenzo Silani. Lancet Neurol 2014
167
22

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.
B R Brooks, R G Miller, M Swash, T L Munsat. Amyotroph Lateral Scler Other Motor Neuron Disord 2000
22

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).
J M Cedarbaum, N Stambler, E Malta, C Fuller, D Hilt, B Thurmond, A Nakanishi. J Neurol Sci 1999
19

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS.
Namita A Goyal, James D Berry, Anthony Windebank, Nathan P Staff, Nicholas J Maragakis, Leonard H van den Berg, Angela Genge, Robert Miller, Robert H Baloh, Ralph Kern,[...]. Muscle Nerve 2020
12
58

Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
F Kimura, C Fujimura, S Ishida, H Nakajima, D Furutama, H Uehara, K Shinoda, M Sugino, T Hanafusa. Neurology 2006
281
16

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
Merit E Cudkowicz, Leonard H van den Berg, Jeremy M Shefner, Hiroshi Mitsumoto, Jesus S Mora, Albert Ludolph, Orla Hardiman, Michael E Bozik, Evan W Ingersoll, Donald Archibald,[...]. Lancet Neurol 2013
150
16

Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis.
Ruben Pa van Eijk, Marinus Jc Eijkemans, Dimitris Rizopoulos, Leonard H van den Berg, Stavros Nikolakopoulos. Clin Epidemiol 2018
16
37

Improved stratification of ALS clinical trials using predicted survival.
James D Berry, Albert A Taylor, Danielle Beaulieu, Lisa Meng, Amy Bian, Jinsy Andrews, Mike Keymer, David L Ennist, Bernard Ravina. Ann Clin Transl Neurol 2018
13
38

Amyotrophic Lateral Sclerosis.
Robert H Brown, Ammar Al-Chalabi. N Engl J Med 2017
592
13

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients.
Koji Abe, Yasuto Itoyama, Gen Sobue, Shoji Tsuji, Masashi Aoki, Manabu Doyu, Chikuma Hamada, Kazuoki Kondo, Takatomo Yoneoka, Makoto Akimoto,[...]. Amyotroph Lateral Scler Frontotemporal Degener 2014
160
13

Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.
Ruben P A van Eijk, Marinus J C Eijkemans, Toby A Ferguson, Stavros Nikolakopoulos, Jan H Veldink, Leonard H van den Berg. J Neurol Neurosurg Psychiatry 2018
40
13

Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study.
Ryuji Kaji, Takashi Imai, Yasuo Iwasaki, Koichi Okamoto, Masanori Nakagawa, Yasuo Ohashi, Takao Takase, Takahisa Hanada, Hiroki Shimizu, Kunio Tashiro,[...]. J Neurol Neurosurg Psychiatry 2019
22
22

Amyotrophic lateral sclerosis.
Michael A van Es, Orla Hardiman, Adriano Chio, Ammar Al-Chalabi, R Jeroen Pasterkamp, Jan H Veldink, Leonard H van den Berg. Lancet 2017
401
13


Amyotrophic lateral sclerosis.
Matthew C Kiernan, Steve Vucic, Benjamin C Cheah, Martin R Turner, Andrew Eisen, Orla Hardiman, James R Burrell, Margaret C Zoing. Lancet 2011
13

Prognostic factors in ALS: A critical review.
Adriano Chiò, Giancarlo Logroscino, Orla Hardiman, Robert Swingler, Douglas Mitchell, Ettore Beghi, Bryan G Traynor. Amyotroph Lateral Scler 2009
531
11


EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.
Peter M Andersen, Sharon Abrahams, Gian D Borasio, Mamede de Carvalho, Adriano Chio, Philip Van Damme, Orla Hardiman, Katja Kollewe, Karen E Morrison, Susanne Petri,[...]. Eur J Neurol 2012
553
11

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.
Merit E Cudkowicz, Sarah Titus, Marianne Kearney, Hong Yu, Alexander Sherman, David Schoenfeld, Douglas Hayden, Amy Shui, Benjamin Brooks, Robin Conwit,[...]. Lancet Neurol 2014
128
11

Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial.
Jesus S Mora, Angela Genge, Adriano Chio, Conrado J Estol, Delia Chaverri, Maria Hernández, Saúl Marín, Javier Mascias, Gabriel E Rodriguez, Monica Povedano,[...]. Amyotroph Lateral Scler Frontotemporal Degener 2020
54
11

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.
Ching-Hua Lu, Corrie Macdonald-Wallis, Elizabeth Gray, Neil Pearce, Axel Petzold, Niklas Norgren, Gavin Giovannoni, Pietro Fratta, Katie Sidle, Mark Fish,[...]. Neurology 2015
273
11


Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study.
Ton Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey, Ashley Jones, P Nigel Leigh, Gilbert Bensimon, Ammar Al-Chalabi. Lancet Neurol 2018
85
11

A proposed staging system for amyotrophic lateral sclerosis.
Jose C Roche, Ricardo Rojas-Garcia, Kirsten M Scott, William Scotton, Catherine E Ellis, Rachel Burman, Lokesh Wijesekera, Martin R Turner, P Nigel Leigh, Christopher E Shaw,[...]. Brain 2012
186
11

Clinical trials in amyotrophic lateral sclerosis.
Christopher J McDermott. Curr Opin Neurol 2019
10
40

Disease-modifying therapies in amyotrophic lateral sclerosis.
Adriano Chiò, Letizia Mazzini, Gabriele Mora. Neuropharmacology 2020
24
16

Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials.
Ruben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, Bas M Middelkoop, Toby A Ferguson, Pamela J Shaw, P Nigel Leigh, Ammar Al-Chalabi, Marinus J C Eijkemans, Leonard H van den Berg. J Neurol Neurosurg Psychiatry 2019
6
66

Analysis of start-up, retention, and adherence in ALS clinical trials.
Nazem Atassi, Padmaja Yerramilli-Rao, Jackie Szymonifka, Hong Yu, Marianne Kearney, Daniela Grasso, Jing Deng, Mark Levine-Weinberg, Jordan Shapiro, Alexandra Lee,[...]. Neurology 2013
22
18



Scrutinizing enrollment in ALS clinical trials: room for improvement?
Richard S Bedlack, Daniel M Pastula, Emily Welsh, Darlene Pulley, Merit E Cudkowicz. Amyotroph Lateral Scler 2008
28
10

Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial.
Esther Verstraete, Jan H Veldink, Mark H B Huisman, Tim Draak, Esther V Uijtendaal, Anneke J van der Kooi, H Jurgen Schelhaas, Marianne de Visser, Ingeborg van der Tweel, Leonard H van den Berg. J Neurol Neurosurg Psychiatry 2012
50
8

ALS longitudinal studies with frequent data collection at home: study design and baseline data.
Seward B Rutkove, Kristin Qi, Kerisa Shelton, Julie Liss, Visar Berisha, Jeremy M Shefner. Amyotroph Lateral Scler Frontotemporal Degener 2019
22
13

Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis.
Jinsy A Andrews, Lisa Meng, Sarah F Kulke, Stacy A Rudnicki, Andrew A Wolff, Michael E Bozik, Fady I Malik, Jeremy M Shefner. JAMA Neurol 2018
31
9

Edaravone: a new treatment for ALS on the horizon?
Orla Hardiman, Leonard H van den Berg. Lancet Neurol 2017
47
8

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.
K E Morrison, S Dhariwal, R Hornabrook, L Savage, D J Burn, T K Khoo, J Kelly, C L Murphy, A Al-Chalabi, A Dougherty,[...]. Lancet Neurol 2013
84
8

Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis.
Sanne Piepers, Jan H Veldink, Sonja W de Jong, Ingeborg van der Tweel, W-Ludo van der Pol, Esther V Uijtendaal, H Jurgen Schelhaas, Hans Scheffer, Marianne de Visser, J M B Vianney de Jong,[...]. Ann Neurol 2009
83
8

Biomarkers in amyotrophic lateral sclerosis.
Martin R Turner, Matthew C Kiernan, P Nigel Leigh, Kevin Talbot. Lancet Neurol 2009
307
8

Quantifying disease progression in amyotrophic lateral sclerosis.
Neil G Simon, Martin R Turner, Steve Vucic, Ammar Al-Chalabi, Jeremy Shefner, Catherine Lomen-Hoerth, Matthew C Kiernan. Ann Neurol 2014
104
8


Decoding ALS: from genes to mechanism.
J Paul Taylor, Robert H Brown, Don W Cleveland. Nature 2016
903
8

An Overview of MicroRNAs as Biomarkers of ALS.
Greig Joilin, P Nigel Leigh, Sarah F Newbury, Majid Hafezparast. Front Neurol 2019
28
10

Electrodiagnostic criteria for diagnosis of ALS.
Mamede de Carvalho, Reinhard Dengler, Andrew Eisen, John D England, Ryuji Kaji, Jun Kimura, Kerry Mills, Hiroshi Mitsumoto, Hiroyuki Nodera, Jeremy Shefner,[...]. Clin Neurophysiol 2008
646
8

Lunasin does not slow ALS progression: results of an open-label, single-center, hybrid-virtual 12-month trial.
R S Bedlack, Paul Wicks, Timothy Vaughan, Alicia Opie, Rebecca Blum, Amanda Dios, Ghazaleh Sadri-Vakili. Amyotroph Lateral Scler Frontotemporal Degener 2019
12
25

The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials.
James D Berry, Robert Miller, Dan H Moore, Merit E Cudkowicz, Leonard H van den Berg, Douglas A Kerr, Yingwen Dong, Evan W Ingersoll, Donald Archibald. Amyotroph Lateral Scler Frontotemporal Degener 2013
53
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.